We want your expertise. MM&M is looking for industry executives and thought leaders to participate in the MM&M/Deloitte Consulting Healthcare Marketers Survey. The online questionnaire takes 10 to 15 minutes, and each qualifying respondent will receive a $25 Amazon gift card. All answers will be kept confidential and used as part of the overall survey results. Go here to participate.
Three topics dominating discussion on day one of the JP Morgan Healthcare Conference in San Francisco were deals, access and affordability, and price gouging — with a new suspect to blame for No. 3. (MM&M)
The number of cancer deaths has dropped by 27% over 25 years, meaning 2.6 million fewer deaths from cancer over that period, according to research from the American Cancer Society. Researchers credited decreases in smoking in large part for the reductions in cancer deaths. (Wall Street Journal)
The Supreme Court decided on Monday that it would not hear an appeal by Merck of a ruling that it could not collect a verdict of $200 million from Gilead from a hepatitis C patent dispute. A jury awarded Merck $200 million in 2016 for patent infringement, but a judge later ruled that those patents were unenforceable due to a pattern of misconduct by Merck. (Reuters)
GlaxoSmithKline CEO Emma Walmsley said she is optimistic she can reinvigorate the company after two December acquisitions, telling CNBC, “I think we have tremendous opportunities to improve both operating performance and get radical about reshaping our portfolio.” GSK said in December that it is planning to buy Tesaro for $5.1 billion and announced a joint venture with Pfizer. (CNBC)
